BRIEF RESEARCH REPORT article
Front. Bioeng. Biotechnol.
Sec. Tissue Engineering and Regenerative Medicine
The Use of Human Decellularized Amniotic Membrane as Pulmonary Valve Leaflets in Right Ventricular Outflow Tract Reconstruction – An in vivo Proof of Concept Study
Provisionally accepted- 1Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, United Kingdom
- 2Fondazione Ri.MED, Palermo, Italy
- 3University of Bristol, Bristol, United Kingdom
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract Introduction. Despite fundamental improvements in surgical treatment of Congenital Heart Defects, there are still challenges related to premature failure of the material used for such corrections, thus resulting in repeated operations during a patient's life. This is particularly the case for complex defects with Right Ventricular Outflow Tract (RVOT) obstruction, such as in Tetralogy of Fallot/Pulmonary Atresia, whereby the pulmonary valve reconstruction remains problematic due to short-term durability of the currently used replacement solutions. We set out to test, for the first time, the suitability of amniotic membrane derived from human placenta for use in cardiovascular replacement of pulmonary valve. Methods. The decellularized and preserved amniotic membrane, obtained through our optimised protocol, was characterised for mechanical and hydrodynamic properties in vitro, and then implanted in the RVOT position of two Landrace piglets for in vivo feasibility and performance evaluation. Results. Both the in vitro and in vivo assessments showed favourable outcomes. The decellularized amniotic membrane had mechanical properties comparable to the native porcine pulmonary valve leaflets. In hydrodynamic testing, the decellularized amniotic membrane-made valve exhibited favourable opening dynamics, with smooth and coordinated leaflet motion throughout the cycle. In vivo, the decellularized amniotic membrane-based valved conduit showed patency in the short-and long-term with no sign of stenosis or regurgitation. Discussion. This study provides an in vivo proof of concept that the decellularized amniotic membrane can be implanted and perform as functional pulmonary valve in a porcine animal model mimicking the clinical scenario of Tetralogy of Fallot surgical correction in infants.
Keywords: Amniotic membrane, Pre-clinical study, Pulmonary Valve, Right ventricular outflow tract reconstruction, swine model
Received: 30 Oct 2025; Accepted: 12 Jan 2026.
Copyright: © 2026 Ghorbel, Salih, Parolari, Skeffington, Di Leonardo, Vella, Burriesci, Caputo and IACOBAZZI. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Mohamed T Ghorbel
DOMINGA IACOBAZZI
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
